356 related articles for article (PubMed ID: 11446654)
1. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
2. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
Karch H; Köhler B
Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
[TBL] [Abstract][Full Text] [Related]
3. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
Allerberger F; Sölder B; Caprioli A; Karch H
Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
[TBL] [Abstract][Full Text] [Related]
5. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].
Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M
Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441
[TBL] [Abstract][Full Text] [Related]
6. Enterohaemorrhagic Escherichia coli O26:H11/H-: a human pathogen in emergence.
Bielaszewska M; Zhang W; Mellmann A; Karch H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):279-87. PubMed ID: 17715820
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
[TBL] [Abstract][Full Text] [Related]
8. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
9. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans.
Orth D; Grif K; Zimmerhackl LB; Würzner R
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):101-8. PubMed ID: 18251667
[TBL] [Abstract][Full Text] [Related]
11. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
[TBL] [Abstract][Full Text] [Related]
12. Enterohaemorrhagic Escherichia coli in human medicine.
Karch H; Tarr PI; Bielaszewska M
Int J Med Microbiol; 2005 Oct; 295(6-7):405-18. PubMed ID: 16238016
[TBL] [Abstract][Full Text] [Related]
13. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
Karch H; Mellmann A; Bielaszewska M
Berl Munch Tierarztl Wochenschr; 2009; 122(11-12):417-24. PubMed ID: 19999376
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of typical hemolytic uremic syndrome.
Karpman D; Sartz L; Johnson S
Semin Thromb Hemost; 2010 Sep; 36(6):575-85. PubMed ID: 20865634
[TBL] [Abstract][Full Text] [Related]
16. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina].
Rivero MA; Padola NL; Etcheverría AI; Parma AE
Medicina (B Aires); 2004; 64(4):352-6. PubMed ID: 15338982
[TBL] [Abstract][Full Text] [Related]
17. Microevolution of epidemiological highly relevant non-O157 enterohemorrhagic Escherichia coli of serogroups O26 and O111.
Eichhorn I; Semmler T; Mellmann A; Pickard D; Anjum MF; Fruth A; Karch H; Wieler LH
Int J Med Microbiol; 2018 Dec; 308(8):1085-1095. PubMed ID: 30115547
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
[TBL] [Abstract][Full Text] [Related]
19. [The epidemiology of human enterohemorrhagic Escherichia coli infections in Lower Saxony].
Dreesman J; Pulz M
Dtsch Tierarztl Wochenschr; 2004 Aug; 111(8):317-20. PubMed ID: 15469059
[TBL] [Abstract][Full Text] [Related]
20. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium.
Bielaszewska M; Karch H
Thromb Haemost; 2005 Aug; 94(2):312-8. PubMed ID: 16113820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
